The Compatibility of Common Respiratory Therapy Drug Combinations
Download in electronic PDF format for $75
Abstract: Respiratory therapists are being asked to take care of sicker
patients and in many cases this requires the administration of
multiple inhalation drugs. In an effort to reduce the workload,
therapists are combining drugs in the same nebulizer. Pharmacists
also are being asked to prepare unit dose preparations
of combined inhalation drugs without physical compatibility
data. It is theorized that some drug combinations precipitate
and that these particulates are ultimately inhaled into the patient’s
lungs. These particulates can cause locally high concentrations
of drug resulting in tissue irritation or actual
occlusion of the airway. This study tested the physical compatibility
of 22 common combinations used in our hospital and
found 19 of these combinations incompatible. Due to the potential
of precipitation,we recommend that inhalation drugs
not be routinely combined without specific compatibility data.
Related Keywords:
Respiratory therapy, drug combinations, incompatibility of, Respiratory therapy, precipitation of drugs in
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
The Compatibility of Common Respiratory Therapy Drug Combinations
Owsley Heather D, Rusho William F
|
Mar/Apr 1997
Pg. 121-122
|
The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
|
Nov/Dec 2001
Pg. 462-464
|
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Dillon L R
|
Jan/Feb 2020
Pg. 30-36
|
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Stephenson Kenna, Jones William, Stephenson Douglas M M
|
May/Jun 2006
Pg. 175-183
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Sterile Compounding of Respiratory Inhalation Solutions
Roberts Rob, Moore Eddie
|
Nov/Dec 2002
Pg. 415-417
|
Technology Spotlight: Respiratory Vial Sealers
Allen Loyd V Jr
|
Sep/Oct 2003
Pg. 364-365
|
Does Your Drug Expertise Include Clinical Pharmaceutics?
Newton David W
|
May/Jun 2016
Pg. 202-206
|
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 356
|
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Fields Shannon W
|
May/Jun 2007
Pg. 200
|
Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 416
|
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 44-50
|
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja, Krämer Irene, Kamin Wolfgang
|
May/Jun 2013
Pg. 254-261
|
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
|
Nov/Dec 2011
Pg. 526-527
|
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Anderson Derick
|
Jan/Feb 2007
Pg. 56-58
|
Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Wepfer Scott T
|
Mar/Apr 2002
Pg. 142-146
|
High-tech Compounding: State-of-the-art Equipment Improves Products and Profit
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 412-419
|
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R, Zava David T
|
Jul/Aug 2003
Pg. 250-256
|
Drugs Banned for Use in Food Animals: An Explanation
Davidson Gigi S
|
Mar/Apr 2001
Pg. 101-103
|
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr, Williams LaVonn A
|
Jul/Aug 2012
Pg. 294-298
|
| Return to Top |
